Aurélie De Bruycker

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Piet Ost, Dries Reynders, Karel Decaestecker et al. · Journal of Clinical Oncology · 2017 · 1.3K citations

Mdt Arm, Urology, Surgical Oncology +12

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

Matthew P. Deek, Kim Van der Eecken, Philip Sutera et al. · Journal of Clinical Oncology · 2022 · 222 citations · Full text

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence (STOMP): Five-year results of a randomized phase II trial.

Piet Ost, Dries Reynders, Karel Decaestecker et al. · Journal of Clinical Oncology · 2020 · 148 citations

Cancer Management, Five-year Results, Oncology +16

Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study

Thomas Steuber, Cordula A. Jilg, Pierre Tennstedt et al. · European Urology Focus · 2018 · 106 citations

Urology, Genitourinary Cancer, Medicine +7

PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial

Aurélie De Bruycker, An Spiessens, Piet Dirix et al. · BMC Cancer · 2020 · 82 citations · Full text